SPANX-N5 inhibitors comprise a diverse group of chemical compounds that exert their inhibitory effects through interference with various cellular signaling cascades and kinase activities that are crucial for maintaining the functional state of SPANX-N5. Kinase inhibitors play a pivotal role by targeting ATP binding sites, thereby hindering phosphorylation events essential for SPANX-N5 activity. This blockade cripples the protein's ability to undergo conformational changes that activate its functions. Notably, certain compounds specifically obstruct protein kinase C, which is vital for downstream signaling that could affect SPANX-N5's role in cellular processes. By halting the activation of key kinases, these inhibitors effectively diminish the potential for SPANX-N5 to participate in its typical cellular roles.
Complementing the action of kinase inhibitors are compounds that impede the phosphoinositide 3-kinases and downstream molecules such as AKT, which are integral to the regulation of SPANX-N5. The inhibition of PI3K disrupts a cascade of events that might otherwise culminate in the activation of SPANX-N5, while AKT inhibitors directly thwart any phosphorylation and subsequent activation of the protein. Additionally, the disruption of mTOR signaling and cytoskeletal dynamics by specific inhibitors provides a multi-faceted approach to stymieing SPANX-N5, as these processes are fundamental to the survival and structural integrity of cells, thereby indirectly impacting SPANX-N5's capacity to function optimally. Moreover, the inhibition of proteasome activity contributes to the accumulation of improperly folded proteins, including potentially non-functional SPANX-N5, further inhibiting its cellular activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that interferes with ATP binding sites. It would inhibit SPANX-N5 phosphorylation, leading to inhibition. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A specific inhibitor of protein kinase C which could attenuate downstream signaling affecting SPANX-N5 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A phosphoinositide 3-kinases (PI3K) inhibitor, reducing AKT activation and potentially inhibiting SPANX-N5. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK1/2 preventing activation of ERK1/2, which may lead to reduced activity of SPANX-N5. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An AKT inhibitor that could prevent SPANX-N5 from being phosphorylated and activated. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that could disturb cellular survival pathways, indirectly affecting SPANX-N5 activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that could lead to accumulation of misfolded SPANX-N5, inhibiting its function. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
A protein kinase C inhibitor which could prevent activation of pathways necessary for SPANX-N5 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An ERK inhibitor that may impede pathways crucial for the proper functionality of SPANX-N5. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent PI3K inhibitor that could indirectly lead to decreased SPANX-N5 activity by affecting downstream signaling. | ||||||